Abstract | BACKGROUND: PROCEDURE: A retrospective review of health records was conducted for pediatric oncology in-patients who were prescribed methylnaltrexone between May 2008 and September 2012 at The Hospital for Sick Children. Demographic, clinical, efficacy, and safety data were collected, including; opioid, laxative, and methylnatrexone dosing and frequency. RESULTS: Fifteen patients (median age: 14 years, range: 4-17 years) received methylnaltrexone; 12 received a single dose while three received multiple doses. At the time of methylnaltrexone administration, patients were receiving a median oral morphine dose equivalent of 5.7 mg/kg/day (range: 1.5-29.2 mg/kg/day) and had not had any bowel movements for several days despite treatment with multiple laxatives. Methylnaltrexone was given at a mean dose of 0.15 ± 0.02 mg/kg/dose (range: 3-12 mg/dose) as a subcutaneous injection. After 14 of 19 doses administered, patients had a bowel movement within 4 hours. Three patients had documented mild gastrointestinal upset following methylnaltrexone administration. None reported a reduction of pain control or opioid withdrawal symptoms. CONCLUSION:
|
Authors | Amelia Rodrigues, Cherie Wong, Andrea Mattiussi, Sarah Alexander, Elaine Lau, L Lee Dupuis |
Journal | Pediatric blood & cancer
(Pediatr Blood Cancer)
Vol. 60
Issue 10
Pg. 1667-70
(Oct 2013)
ISSN: 1545-5017 [Electronic] United States |
PMID | 23766091
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | Copyright © 2013 Wiley Periodicals, Inc. |
Chemical References |
- Analgesics, Opioid
- Narcotic Antagonists
- Quaternary Ammonium Compounds
- methylnaltrexone
- Naltrexone
|
Topics |
- Adolescent
- Analgesics, Opioid
(administration & dosage, adverse effects)
- Child
- Child, Preschool
- Constipation
(chemically induced, drug therapy, physiopathology)
- Female
- Humans
- Male
- Naltrexone
(administration & dosage, analogs & derivatives)
- Narcotic Antagonists
(administration & dosage)
- Neoplasms
- Pain
(drug therapy, etiology)
- Quaternary Ammonium Compounds
(administration & dosage)
- Retrospective Studies
|